Abstract
This chapter contains sections titled:
Introduction
Natural History of Recurrent Hcv
Factors Associated with Severe HCV Recurrence
Treatment of Recurrent HCV
Pre‐Transplant Antiviral Therapy
Preemptive Antiviral Therapy
Treatment of Established Disease
Maintenance Therapy
Risk of Acute Cellular Rejection
Retransplantation for Allograft Cirrhosis
Unanswered Questions and the Future
Liver Transplantation for Hepatitis B Virus (HBV) Infection
Initial Experience with OLT for HBV
Identification of Predictors of Recurrence of HBV
The Oral Nucleoside Monotherapy ERA
Combination HBIG and Lamivudine
Role of Immunization
Transmission of HBV Infection by Donor Grafts
Impact of Oral Therapy On Requirement for Liver Transplant
Future Directions
References